We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

FDA Approves First Supplemental Test for Chagas Disease

The U.S. Food and Drug Administration have approved the first test for use as an additional, more specific test on human serum or plasma specimens found to be positive for antibodies to T. cruzi, which causes Chagas disease, a serious and potentially fatal parasitic infection.
News

Kamada Launches New Website for its Human Ultrapure Transferrin

Kamada, a biopharmaceutical company developing, manufacturing and marketing specialty life-saving therapeutics, has announced the launching of a new e-commerce website for its Human Ultrapure Transferrin.
News

Geron to Focus on its Novel Cancer Programs

Geron Corporation has announced that they will be focusing on first-in-class oncology programs. As a consequence, the Company will discontinue further development of its stem cell programs and is seeking partners for these novel assets.
News

InteRNA Technologies Announces Establishment of Supervisory Board

InteRNA Technologies B.V., a drug discovery and development company engaged in the development of microRNA-based therapeutics for oncology, has announced the establishment of its Supervisory Board.
News

NHS Urged to Prepare for ‘Genetic Revolution’

The ability to bring biologists into the data analysis phase will be key to achieving this important goal.
News

Chimps’ Lab Days Numbered

Advocacy groups pushing to end research in U.S.
News

Retina Implant AG Gains Approval To Expand Clinical Trial Across Europe

Majority of Patients Report Restoration of Useful Vision in Daily Life
News

Strategic Alliances to Host Special Sessions at SLAS2012

Three industry partners to discuss global scientific trends.
News

Monoolein Lipid Phases as Incorporation and Enrichment Materials for Membrane Protein Crystallization

In this study researchers have shown that the formation of the lipidic phases and the incorporation of the membrane protein into such materials can be separated experimentally.
News

Key Patents Issued to Celerus Diagnostics

Company Secures Long-term Control of Rapid IHC® Technologies
Advertisement